SEC 13F Intelligence

S. Muoio & Co. LLC / AIMT

S. Muoio & Co. LLC’s Aimmune Therapeutics Inc Position

Does S. Muoio & Co. LLC own Aimmune Therapeutics Inc (AIMT)? Not currently — the last reported position was 90.0K shares worth $3M in Q3 2020; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$3M
Q3 2020
Shares
90.0K
% of Portfolio
+3.52%
Quarters Held
1
position exited

Position History AIMT

Reported value by quarter
Q3 ’20: $3MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202090.0K$3M+3.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See S. Muoio & Co. LLC’s full portfolio or all institutional holders of AIMT.